Many Elderly Patients with Metastatic Renal Cell Carcinoma Benefit from Targeted Therapies

Article from Medical Xpress curated by Editor in Chief George Lundberg, MD, who notes: 

Ageism (bias against the elderly) is a real issue in the selection of patients to be included in clinical trials. A new study demonstrates how such bias may harm the elderly with renal cell carcinoma.

Go to full article published by Medical Xpress.

If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.